| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 8,580 | 7,090 | 8,230 | 3,180 | 8,530 |
| Sales Growth | +21.02% | -13.85% | +158.81% | -62.72% | -64.61% |
| Net Income | -78,430 | -75,560 | -62,460 | -59,310 | -154,200 |
| Net Income Growth | -3.80% | -20.97% | -5.31% | +61.54% | -149.60% |
Asensus Surgical Inc (ASXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Asensus Surgical Inc. is a medical device company which is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM). Asensus Surgical Inc., formerly known as TransEnterix Inc., is based in RESEARCH TRIANGLE PARK, N.C.
Fiscal Year End Date: 12/31